Free Trial

InnovAge (OTCMKTS:INNV) Shares Gap Up - Here's What Happened

InnovAge logo with Medical background

Key Points

  • InnovAge Holding Corp. (OTCMKTS:INNV) experienced a notable increase in share price, opening at $4.86 after a previous close of $4.63, and last traded at $4.95.
  • The company has a market cap of $671.41 million and a negative P/E ratio of -15.97, indicating it has not generated profit over the last year.
  • InnovAge specializes in medical and ancillary services for seniors, utilizing a Program of All-Inclusive Care for the Elderly (PACE) approach to support independent living.
  • Interested in InnovAge? Here are five stocks we like better.

InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $4.63, but opened at $4.86. InnovAge shares last traded at $4.95, with a volume of 2,317 shares trading hands.

InnovAge Price Performance

The company has a debt-to-equity ratio of 0.25, a current ratio of 1.57 and a quick ratio of 1.57. The firm's 50 day moving average is $3.90 and its 200 day moving average is $3.65. The firm has a market cap of $671.41 million, a P/E ratio of -15.97 and a beta of 0.52.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.